We are live on ! Find out more
CLRB icon

Cellectar Biosciences
CLRB

10 hedge funds and large institutions have $505K invested in Cellectar Biosciences in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0% → 0% (-0%)

29% less funds holding

Funds holding: 14 → 10 (-4)

72% less capital invested

Capital invested by funds: $1.82M → $505K (-$1.32M)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
10
Holders Change
-4
Holders Change %
-28.57%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
+$25K
2
Creative Planning
Creative Planning
Kansas
+$17.9K
3
Northern Trust
Northern Trust
Illinois
+$10.7K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$7.15K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$678K
2
AFM
Anson Funds Management
Texas
-$523K
3
VF
Virtu Financial
New York
-$55K
4
Citadel Advisors
Citadel Advisors
Florida
-$19K
5
UBS Group
UBS Group
Switzerland
-$10.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$277K +$7.15K +2 +3%
State Street
2
State Street
Massachusetts
$62K – – –
TSS
3
Two Sigma Securities
New York
$41K +$25K +7 +140%
Northern Trust
4
Northern Trust
Illinois
$33K +$10.7K +3 +43%
US Bancorp
5
US Bancorp
Minnesota
$32K – – –
Creative Planning
6
Creative Planning
Kansas
$18K +$17.9K +5 New
IGGA
7
Iron Gate Global Advisors
Utah
$15K – – –
AIC
8
AWM Investment Company
New York
$13K – – –
Morgan Stanley
9
Morgan Stanley
New York
$6K – – –
SIM
10
Sonora Investment Management
Arizona
$5.67K – – –
BlackRock
11
BlackRock
New York
$1K – – –
WAM
12
Wealthspire Advisors (Maryland)
Maryland
$1K – – –
APA
13
American Portfolios Advisors
New York
$1 – – –
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
– -$678K -165 Closed
AFM
15
Anson Funds Management
Texas
– -$523K -127 Closed
VF
16
Virtu Financial
New York
– -$55K -13 Closed
Citadel Advisors
17
Citadel Advisors
Florida
– -$19K -5 Closed
UBS Group
18
UBS Group
Switzerland
– -$10.7K -3 Closed

CLRB Hedge Fund Activity: Q1 2018 in Review

10 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences (CLRB) for Q1 2018, worth a combined $505K — down 72% from $1.82M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of CLRB and 1 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 3 added.

The largest buyer was Two Sigma Securities, adding an estimated $25K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $678K sold.

  • 10 institutional investors held Cellectar Biosciences (CLRB) as of Q1 2018, down from 14 in Q4 2017.
  • Funds reported $505K of Cellectar Biosciences stock for Q1 2018, down 72% quarter-over-quarter.
  • 1 fund opened new Cellectar Biosciences positions in Q1 2018 and 5 closed out, a net change of -4 holders.
  • The largest Cellectar Biosciences buyer in Q1 2018 was Two Sigma Securities, an estimated $25K added.
  • The largest Cellectar Biosciences seller in Q1 2018 was Susquehanna International Group, an estimated $678K sold.

Based on aggregated 13F filings for Q1 2018.